Media

Filter by Category

All Blogs Presentations Press Releases Publications Videos

Filter by Program

Filter by Publish Date

Global Health Partners Accelerate Uptake of Genetic Sequencing for Surveillance And Diagnosis Of Drug-Resistant Tuberculosis

WHO adopts ReSeqTB as bioinformatics platform for TB surveillance, enabling the global scale-up of culture-free,

March 14, 2018

Towards Bridging Translational Gap in Cardiotoxicity Prediction: an Application of Progressive Cardiac Risk Assessment Strategy in TdP Risk Assessment of Moxifloxacin

November 3, 2018

D-RSC presents poster on advancing drug development for Duchenne through data sharing and quantitative tool development at the 2018 MDA Clinical Conference

August 3, 2018

Quantitative Approach for Cardiac Risk Assessment and Interpretation in Tuberculosis Drug Development

February 28, 2018

Patient-Reported Outcome (PRO) Consortium Translation Process: Consensus Development of Updated Best Practices

February 20, 2018

2018 ISCTM Distinguished Poster Award Winner: “Global Regulatory Agencies Support Dopamine Transporter Neuroimaging in Clinical Trials Targeting Parkinson’s disease”

Tucson-based Critical Path Institute emerging as top drug-research organization

President and CEO Dr. Martha Brumfield was recently interviewed by the Arizona Daily Star for a profile on C-Path published Februa

Critical Path to TB Drug Regimens (CPTR) 2018 Annual Workshop, postponed

Critical Path Institute and Bill & Melinda Gates Foundation have decided to postpone the Critical Path to TB Drug Regimens Wor

January 22, 2018

Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effort

Critical Path Institute Receives Regulatory Support for Liver Injury Biomarker

Tucson, AZ — January 22, 2018 — Critical Path Institute (C-Path) announced today that the European Medicines Agency (E

Previous6061 62...109 Next